BamSEC and AlphaSense Join Forces
Learn More

Lifecore Biomedical Inc. – Material Contracts

Formerly NASDAQ: LFCR

Material Contracts Filter

EX-10.1
from 8-K 6 pages Lifecore Biomedical, Inc. Incentive Bonus Plan
12/34/56
EX-10.2
from 10-Q 9 pages Consent and Omnibus Amendment
12/34/56
EX-10.1
from 10-Q 10 pages Consent and Omnibus Amendment
12/34/56
EX-10.41
from 10-K 9 pages Employment Agreement
12/34/56
EX-10.39
from 10-K 3 pages May 9, 2025 Re: Amendment to Offer Letter Dated March 20, 2024 Between Paul Josephs and Lifecore Biomedical, Inc. (The “Offer Letter”) Dear Paul: This Letter Sets Forth an Amendment (“Amendment”) to the Offer Letter That Has Been Mutually Agreed Between, and Duly Authorized By, You and Lifecore. All Capitalized Terms Used in This Amendment and Not Otherwise Defined Shall Have the Meanings Set Forth in the Offer Letter. the Parties Have Duly Executed This Amendment as of the Date First Set Forth Above
12/34/56
EX-10.33
from 10-K 3 pages Amendment No. 2 to Amended and Restated Contract Manufacturing Agreement
12/34/56
EX-10.1
from 8-K 1 page Lifecore Biomedical, Inc. First Amendment to Equity Inducement Plan Effective Date April 11, 2025
12/34/56
EX-10.1
from 8-K 59 pages Lifecore Biomedical, Inc. Stock Purchase Agreement
12/34/56
EX-10.1
from 8-K 9 pages Employment Agreement
12/34/56
EX-10.1
from 8-K 18 pages Lifecore Biomedical, Inc. 2019 Stock Incentive Plan as Amended Through March 20, 2024
12/34/56
EX-10.3
from 8-K 27 pages Cooperation Agreement
12/34/56
EX-10.2
from 8-K 26 pages Cooperation Agreement
12/34/56
EX-10.1
from 8-K 32 pages Cooperation Agreement
12/34/56
EX-10.3
from 8-K 2 pages Participation Notice Lifecore Biomedical, Inc. Executive Change in Control Severance Plan
12/34/56
EX-10.2
from 8-K 5 pages Lifecore Biomedical, Inc. Equity Inducement Plan Performance Stock Unit Award Agreement
12/34/56
EX-10.1
from 8-K 4 pages Lifecore Biomedical, Inc. Equity Inducement Plan Restricted Stock Unit Award Agreement
12/34/56
EX-10.1
from 8-K 215 pages Material contract
12/34/56
EX-10.1
from 8-K 3 pages Amendment No. 1 to Amended and Restated Contract Manufacturing Agreement
12/34/56
EX-10.3
from 8-K 7 pages Separation Agreement and General Release
12/34/56
EX-10.2
from 8-K 17 pages Lifecore Biomedical, Inc. Equity Inducement Plan Effective Date March 20, 2024
12/34/56